Loading...
    Loading...
    LEADERBOARD
labroots
Login here
Register Free
  • LOGIN
  • REGISTER FREE
  • Home
  • Virtual Events
      • Upcoming
      • On-Demand
      • Companies
      • Posters
      • Categories
      See More
      See More
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Webinars
      • Upcoming
      • On-Demand
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Trending News
      • Most Recent
      • What's Hot
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Drug Discovery & Development
      • Plants & Animals
      • Cannabis Sciences
      • Earth & The Environment
      • Space & Astronomy
      • Chemistry & Physics
      • Technology
  • Multimedia
      • Sponsored Content
      • eBooks
      • Podcasts
      • Infographics
      See More
      See More
      See More
      See More
  • Products
      • Categories
      • Companies
      • New
      • Popular
      Antibodies
      Immunity, Immunoassay, Immunotherapy
      Assay Kits
      Detection, Quantification
      Biomolecules
      Proteins
      Cell Biology
      Cell function
      Cell-Based Assays
      Cell viability
      Cell/Tissue Culture
      Cell lines, Cell growth, Cell differentiation
      Chemicals and Reagents
      Reagent kits, Laboratory chemicals
      Drug Discovery and Development
      Target identification, High-throughput screening
      Flow Cytometry
      Immunophenotyping, Cell cycle analysis
      Genomics
      Genome sequencing, Transcriptomics
      Imaging (Bio-Imaging / Microscopy)
      Fluorescence imaging
      Lab Automation
      High-throughput screening, Robotics, Liquid handling systems
      Lab Equipment
      Centrifuges, Incubators, Homogenizers, Sonicators
      Life Sciences
      Biological research, Biotechnology
      Molecular Biology
      DNA replication, Gene expression, PCR
      Next Gen Sequencing
      DNA sequencing, High-throughput sequencing, NGS platforms, RNA sequencing, miRNA sequencing, Accessory Products
      Quality Control and Validation
      QC standards, Quality assurance
      Single Cell Analysis
      Transcriptomics
      Technology
      Biotechnology, Instrumentation, Data analysis
      See More
      See More
      See More
  • Companies
      • See More
    • Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        See More
        See More
        See More
        Gift Card $25
        Gift Card $50
        Gift Card $75
        Gift Card $100
        See More
        Labroots Store Gift Card Balance
        $0.00
        Balance
        Gift Card Number:

        No gift card matches the entered value.

    • Continuing Education
    • More
      • Virtual Events
        • All Virtual Events
        • Upcoming
        • On-Demand
        • Posters
        • Companies
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Webinars
        • All Webinars
        • Upcoming
        • On-Demand
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Trending News
        • Most Recent
        • What's Hot
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Drug Discovery & Development
        • Plants & Animals
        • Cannabis Sciences
        • Earth & The Environment
        • Space & Astronomy
        • Chemistry & Physics
        • Technology
        Multimedia
        • Sponsored Content
        • eBooks
        • Podcasts
        • Infographics
        Store
        Companies
        Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        Continuing Education
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Blog
        • Scholarships
        • RSS
        • Contact Us
        • Continuing Education
        • Leaderboard
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Support
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Media Partnerships
        • Blog
        • Scholarships
        • Continuing Education
        • Leaderboard
        • Contact Us
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Request Demo
        Interested in Advertising
        with Labroots?
        Have questions? Visit our Support pages
    Login here
    Register Free
    Follow

    Tumor

    Tumor: is an abnormal mass of tissue that may be solid or fluid-filled. A tumor is not the same as cancer. Although, some tumors can develop into cancers. A tumor is a kind of lump or swelling and does not necessarily pose a health threat.

    Webinars

    • FEB 05, 2014 | 2:00 PM
      C.E. CREDITS
      The impact of genetic background in mouse and rat models: concerns and solutions
      The impact of genetic background in mouse and rat models: concerns...
      It is increasingly recognized that the genetic background (i.e., all genomic sequences other than the gene(s) of interest) can have profound influences on the phenotype of an animal model. I...
      Speaker: Fernando Benavides, DVM, PhD, DACLAM
      Presented at: Laboratory Animal Sciences Virtual Event Series 2014
      21
      NOV 08, 2013 | 12:00 PM
      Childhood cancer with various genomic assay including whole genome sequencing
      Childhood cancer with various genomic assay including whole genome...
      The NCI's Therapeutically Applicable Research to Generate Effective Treatments (TARGET) is a comprehensive genomic characterization initiative to determine the molecular changes that drive th...
      Speaker: Jaime Guidry Auvil, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      4
      OCT 23, 2013 | 12:00 PM
      Cellular regulation of the molecular chaperone HSP90 by posttranslational modifications - impact on function and drug sensitivity
      Cellular regulation of the molecular chaperone HSP90 by posttranslational...
      Molecular chaperones help nascent polypeptides fold correctly and multimeric protein complexes assemble productively, while minimizing the danger of aggregation in the protein-rich intracellu...
      Speaker: Len Neckers, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      2
      OCT 17, 2013 | 2:00 PM
      C.E. CREDITS
      Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic cancer
      Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic...
      Pancreatic cancer is the 4th most common cause of cancer deaths in the United States. Due to the aggressive nature of this cancer and the lack of biomarkers for early detection, the incidence...
      Speaker: Antonio T. Baines, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      72
      OCT 17, 2013 | 1:00 PM
      C.E. CREDITS
      Transcriptome sequencing in translational oncology research
      Transcriptome sequencing in translational oncology research
      Invading cancer cells leave the tumor to form distant metastases and are ultimately responsible for 90% of deaths in cancer. Reducing the ability of cancer cells to invade and metastasize cou...
      Speaker: Milan Radovich, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      64
      OCT 17, 2013 | 12:00 PM
      C.E. CREDITS
      Embracing the Complexity of Cancer: Seeing the Forest and the Trees
      Embracing the Complexity of Cancer: Seeing the Forest and the...
      Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
      Speaker: Kenneth Buetow, PhD, FACMI
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      34
      OCT 17, 2013 | 12:00 PM
      Biomarkers & Dx test development
      Biomarkers & Dx test development
      The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spit...
      Speaker: Martin Latterich, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      36
      OCT 17, 2013 | 12:00 PM
      C.E. CREDITS
      Cells in Action: Why Cancer Cells Leave the Tumors?
      Cells in Action: Why Cancer Cells Leave the Tumors?
      Invading cancer cells leave the tumor to form distant metastases and are ultimately responsible for 90% of deaths in cancer. Reducing the ability of cancer cells to invade and metastasize cou...
      Speaker: Daniel Irimia, MD, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      140
      OCT 17, 2013 | 11:00 AM
      C.E. CREDITS
      The Need for Critical Reassessment of Current Strategies for Cancer Therapeutics.
      The Need for Critical Reassessment of Current Strategies for Cancer...
      Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
      Speaker: George Poste, DVM, DSc, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      42
      OCT 17, 2013 | 10:00 AM
      C.E. CREDITS
      The Molecular Mechanisms of Castration-Resistant Prostate Cancer
      The Molecular Mechanisms of Castration-Resistant Prostate Cancer
      Prostate cancer epithelial cells depend on androgens for their survival. Because of this dependence, androgen deprivation therapy is the major treatment of advanced prostate cancer. Such ther...
      Speaker: Donald Tindall, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      40
      OCT 17, 2013 | 9:00 AM
      C.E. CREDITS
      Subtyping Circulating Tumor Cells in Breast Cancer for Personalized Therapeutics
      Subtyping Circulating Tumor Cells in Breast Cancer for Personalized...
      Cancer metastases develop when tumor cells known as circulating tumor cells (CTCs) are shed from a tumor, circulate through the blood stream and colonize a distant tissue. The number of CTCs...
      Speaker: Lori M. Millner, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      86
      OCT 17, 2013 | 7:00 AM
      Noninvasive Cancer Genomics
      Noninvasive Cancer Genomics
      Whenever there is cell death, apoptotic cell free DNA fragments appear in the circulation of the host. These fragments, typically 145-160 base pairs in size, represent a minute fraction of to...
      Speaker: Charles Cantor, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      50
      OCT 16, 2013 | 3:00 PM
      C.E. CREDITS
      The roles of Ack family kinases in Drosophila development
      The roles of Ack family kinases in Drosophila development
      Deregulation of ACK1, a non-receptor tyrosine kinase originally identified by its ability to bind to GTP-bound Cdc42 (hence the name: activated Cdc42-associated kinase)(Manser et al., 1993),...
      Speaker: Henry Chang, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      42
      OCT 16, 2013 | 2:00 PM
      C.E. CREDITS
      PSA Screening and Early Detection for Prostate Cancer 2013: Controversy and Opportunity
      PSA Screening and Early Detection for Prostate Cancer 2013: Controversy...
      While the Prostate Specific Antigen (PSA) blood test has been available since 1986 and FDA-approved for the early detection of prostate cancer since the early 1990s, 2012 marked a critical in...
      Speaker: Judd W Moul, MD, FACS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 2:00 PM
      C.E. CREDITS
      Novel therapies for ALK mutated cancers
      Novel therapies for ALK mutated cancers
      Non Small Cell Lung Cancer (NSCLC) is one of the most significant causes of cancer-related mortality worldwide. In about 6-7% of NSCLC, rearrangements involving the Anaplastic Lymphoma Kinase...
      Speaker: Roberto Chiarle, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      32
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Investigating tissue specificity of cancer-causing germline mutations
      Investigating tissue specificity of cancer-causing germline mutations
      The remarkable diversity we see between different cell types in the human body is governed by the specificity attained through transcriptional and epigenetic regulatory programs. Cancer is a...
      Speaker: Jessica C. Mar, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      68
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
      Resistance to AR Signaling Inhibitors in Castration Resistant...
      While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
      Speaker: Elahe A Mostaghel, MD, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
      Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
      Speaker: Kristin Landis-Piwowar, PhD, MLS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      129
      OCT 16, 2013 | 11:00 AM
      Molecular Prognosis in the Management of Early Stage Lung Cancer
      Molecular Prognosis in the Management of Early Stage Lung Cancer
      Survival rates for early stage non-small cell lung cancer (NSCLC) remain unacceptably low compared to other common solid tumors. This mortality reflects a weakness in conventional staging, a...
      Speaker: Michael J Mann, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      58
      OCT 16, 2013 | 11:00 AM
      SuperSelective PCR Primers for the Detection of Rare Mutant Cancer Cells in Clinical Samples Containing Abundant Normal Cells
      SuperSelective PCR Primers for the Detection of Rare Mutant Cancer...
      "SuperSelective" primers, by virtue of their unique design, enable only a few molecules of a mutant sequence to generate amplicons in conventional, real-time PCR assays without interference...
      Speaker: Fred Kramer, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      90
      OCT 16, 2013 | 11:00 AM
      C.E. CREDITS
      Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
      Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
      Cancer and diabetes are complex diseases that have proven difficult to treat in the clinics. Until recently, most efforts have focused on hitting individual therapeutic targets cleanly. Unfor...
      Speaker: Ross L. Cagan, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      78
      OCT 16, 2013 | 9:00 AM
      C.E. CREDITS
      Keynote: Breast Cancer Genomics and Genetics
      Keynote: Breast Cancer Genomics and Genetics
      It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
      Speaker: Charles M. Perou, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      132
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Novel strategies for the targeted delivery of anti-cancer drugs in bladder cancer  CME and CE Credits Available
      Novel strategies for the targeted delivery of anti-cancer drugs...
      The adjuvant therapy of choice for superficial bladder cancer is the intravesical instillation of live Mycobacterium bovis Bacillus Calmette-Guerin (BCG). In spite of the fact that this thera...
      Speaker: R. Claudio Aguilar, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      34
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
      Prognostic, predictive, and surrogate biomarkers in men with castration...
      With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
      Speaker: Andrew Armstrong, MD ScM FACP
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      96
    FEB 05, 2014 | 2:00 PM
    C.E. CREDITS
    The impact of genetic background in mouse and rat models: concerns and solutions
    The impact of genetic background in mouse and rat models: concerns...
    It is increasingly recognized that the genetic background (i.e., all genomic sequences other than the gene(s) of interest) can have profound influences on the phenotype of an animal model. I...
    Speaker: Fernando Benavides, DVM, PhD, DACLAM
    Presented at: Laboratory Animal Sciences Virtual Event Series 2014
    21
    NOV 08, 2013 | 12:00 PM
    Childhood cancer with various genomic assay including whole genome sequencing
    Childhood cancer with various genomic assay including whole genome...
    The NCI's Therapeutically Applicable Research to Generate Effective Treatments (TARGET) is a comprehensive genomic characterization initiative to determine the molecular changes that drive th...
    Speaker: Jaime Guidry Auvil, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    4
    OCT 23, 2013 | 12:00 PM
    Cellular regulation of the molecular chaperone HSP90 by posttranslational modifications - impact on function and drug sensitivity
    Cellular regulation of the molecular chaperone HSP90 by posttranslational...
    Molecular chaperones help nascent polypeptides fold correctly and multimeric protein complexes assemble productively, while minimizing the danger of aggregation in the protein-rich intracellu...
    Speaker: Len Neckers, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    2
    OCT 17, 2013 | 2:00 PM
    C.E. CREDITS
    Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic cancer
    Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic...
    Pancreatic cancer is the 4th most common cause of cancer deaths in the United States. Due to the aggressive nature of this cancer and the lack of biomarkers for early detection, the incidence...
    Speaker: Antonio T. Baines, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    72
    OCT 17, 2013 | 1:00 PM
    C.E. CREDITS
    Transcriptome sequencing in translational oncology research
    Transcriptome sequencing in translational oncology research
    Invading cancer cells leave the tumor to form distant metastases and are ultimately responsible for 90% of deaths in cancer. Reducing the ability of cancer cells to invade and metastasize cou...
    Speaker: Milan Radovich, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    64
     
     
  • OCT 17, 2013 | 12:00 PM
    C.E. CREDITS
    Embracing the Complexity of Cancer: Seeing the Forest and the Trees
    Embracing the Complexity of Cancer: Seeing the Forest and the...
    Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
    Speaker: Kenneth Buetow, PhD, FACMI
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    34
    OCT 17, 2013 | 12:00 PM
    Biomarkers & Dx test development
    Biomarkers & Dx test development
    The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spit...
    Speaker: Martin Latterich, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    36
    OCT 17, 2013 | 12:00 PM
    C.E. CREDITS
    Cells in Action: Why Cancer Cells Leave the Tumors?
    Cells in Action: Why Cancer Cells Leave the Tumors?
    Invading cancer cells leave the tumor to form distant metastases and are ultimately responsible for 90% of deaths in cancer. Reducing the ability of cancer cells to invade and metastasize cou...
    Speaker: Daniel Irimia, MD, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    140
    OCT 17, 2013 | 11:00 AM
    C.E. CREDITS
    The Need for Critical Reassessment of Current Strategies for Cancer Therapeutics.
    The Need for Critical Reassessment of Current Strategies for Cancer...
    Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
    Speaker: George Poste, DVM, DSc, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    42
    OCT 17, 2013 | 10:00 AM
    C.E. CREDITS
    The Molecular Mechanisms of Castration-Resistant Prostate Cancer
    The Molecular Mechanisms of Castration-Resistant Prostate Cancer
    Prostate cancer epithelial cells depend on androgens for their survival. Because of this dependence, androgen deprivation therapy is the major treatment of advanced prostate cancer. Such ther...
    Speaker: Donald Tindall, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    40
     
     
  • OCT 17, 2013 | 9:00 AM
    C.E. CREDITS
    Subtyping Circulating Tumor Cells in Breast Cancer for Personalized Therapeutics
    Subtyping Circulating Tumor Cells in Breast Cancer for Personalized...
    Cancer metastases develop when tumor cells known as circulating tumor cells (CTCs) are shed from a tumor, circulate through the blood stream and colonize a distant tissue. The number of CTCs...
    Speaker: Lori M. Millner, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    86
    OCT 17, 2013 | 7:00 AM
    Noninvasive Cancer Genomics
    Noninvasive Cancer Genomics
    Whenever there is cell death, apoptotic cell free DNA fragments appear in the circulation of the host. These fragments, typically 145-160 base pairs in size, represent a minute fraction of to...
    Speaker: Charles Cantor, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    50
    OCT 16, 2013 | 3:00 PM
    C.E. CREDITS
    The roles of Ack family kinases in Drosophila development
    The roles of Ack family kinases in Drosophila development
    Deregulation of ACK1, a non-receptor tyrosine kinase originally identified by its ability to bind to GTP-bound Cdc42 (hence the name: activated Cdc42-associated kinase)(Manser et al., 1993),...
    Speaker: Henry Chang, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    42
    OCT 16, 2013 | 2:00 PM
    C.E. CREDITS
    PSA Screening and Early Detection for Prostate Cancer 2013: Controversy and Opportunity
    PSA Screening and Early Detection for Prostate Cancer 2013: Controversy...
    While the Prostate Specific Antigen (PSA) blood test has been available since 1986 and FDA-approved for the early detection of prostate cancer since the early 1990s, 2012 marked a critical in...
    Speaker: Judd W Moul, MD, FACS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 2:00 PM
    C.E. CREDITS
    Novel therapies for ALK mutated cancers
    Novel therapies for ALK mutated cancers
    Non Small Cell Lung Cancer (NSCLC) is one of the most significant causes of cancer-related mortality worldwide. In about 6-7% of NSCLC, rearrangements involving the Anaplastic Lymphoma Kinase...
    Speaker: Roberto Chiarle, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    32
     
     
  • OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Investigating tissue specificity of cancer-causing germline mutations
    Investigating tissue specificity of cancer-causing germline mutations
    The remarkable diversity we see between different cell types in the human body is governed by the specificity attained through transcriptional and epigenetic regulatory programs. Cancer is a...
    Speaker: Jessica C. Mar, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    68
    OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
    Resistance to AR Signaling Inhibitors in Castration Resistant...
    While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
    Speaker: Elahe A Mostaghel, MD, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
    Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
    Speaker: Kristin Landis-Piwowar, PhD, MLS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    129
    OCT 16, 2013 | 11:00 AM
    Molecular Prognosis in the Management of Early Stage Lung Cancer
    Molecular Prognosis in the Management of Early Stage Lung Cancer
    Survival rates for early stage non-small cell lung cancer (NSCLC) remain unacceptably low compared to other common solid tumors. This mortality reflects a weakness in conventional staging, a...
    Speaker: Michael J Mann, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    58
    OCT 16, 2013 | 11:00 AM
    SuperSelective PCR Primers for the Detection of Rare Mutant Cancer Cells in Clinical Samples Containing Abundant Normal Cells
    SuperSelective PCR Primers for the Detection of Rare Mutant Cancer...
    "SuperSelective" primers, by virtue of their unique design, enable only a few molecules of a mutant sequence to generate amplicons in conventional, real-time PCR assays without interference...
    Speaker: Fred Kramer, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    90
     
     
  • OCT 16, 2013 | 11:00 AM
    C.E. CREDITS
    Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
    Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
    Cancer and diabetes are complex diseases that have proven difficult to treat in the clinics. Until recently, most efforts have focused on hitting individual therapeutic targets cleanly. Unfor...
    Speaker: Ross L. Cagan, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    78
    OCT 16, 2013 | 9:00 AM
    C.E. CREDITS
    Keynote: Breast Cancer Genomics and Genetics
    Keynote: Breast Cancer Genomics and Genetics
    It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
    Speaker: Charles M. Perou, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    132
    OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Novel strategies for the targeted delivery of anti-cancer drugs in bladder cancer  CME and CE Credits Available
    Novel strategies for the targeted delivery of anti-cancer drugs...
    The adjuvant therapy of choice for superficial bladder cancer is the intravesical instillation of live Mycobacterium bovis Bacillus Calmette-Guerin (BCG). In spite of the fact that this thera...
    Speaker: R. Claudio Aguilar, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    34
    OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
    Prognostic, predictive, and surrogate biomarkers in men with castration...
    With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
    Speaker: Andrew Armstrong, MD ScM FACP
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    96
    Related Tags
    See more See less
    Let's Talk Science. Let's Talk Medicine.

    The leading scientific social networking website and producer of educational virtual events and webinars.

    About Us The Team Contact Us Careers Media Kit Virtual Events Posters Multimedia Blog Press Room Science Store Gift Card Balance
    Continuing Education Scholarships Leaderboard Order Policy Shipping Policy Privacy Policy Terms and Conditions User Agreement User Data Request Copyrights Support Chati
    © 2008-2025 Labroots Inc.
    Opens in a new window Opens an external site Opens an external site in a new window
    Modal title